FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: PHARMACY COMPOUNDING ADVISORY COMMITTEE; NOTICE OF MEETING; ESTABLISHMENT OF A PUBLIC DOCKET; REQUEST FOR COMMENTS-BULK DRUG SUBSTANCES NOMINATED FOR INCLUSION ON THE SECTION 503A BULK DRUG SUBSTANCES LIST

WASHINGTON, April 16 -- Food and Drug Administration has issued a notice called: Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Bulk Drug Substances Nominated for Inclusion on the Section 503A Bulk Drug Substances List.

The notice was published in the Federal Register on April 16 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Pharmacy Compounding Advisory Committee (the Committee). The general function of the Committee is to provide advice and recommendations to FDA on regulatory issues. The meeting will be open to t...